Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharma - API & CRAMS
  4. /Dishman Carbogen Amcis Ltd
MomentumDeep Value

Dishman Carbogen Amcis Ltd: Stock Analysis & Fundamentals

Updated this week

Dishman Carbogen Amcis Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 27.6. ROE: 1.6%. This stock is not currently in the Nifty 500 momentum outperformers list.

Dishman Carbogen Amcis Ltd Key Facts

What's Happening

💪Debt reduced 17% YoY — balance sheet strengthening

Key Numbers

Current Price
₹174
Market Cap
2.7K Cr
Valuation
N/A

Other Top Pharma - API & CRAMS Stocks Beating Nifty 500

Laurus Labs Ltd
Average • 11w streak
+34.1%
Anthem Biosciences Ltd
Average • 10w streak
+10.3%
Gland Pharma Ltd
Average • 5w streak
+27.7%
Acutaas Chemicals Ltd
Average • 12w streak
+23.0%
Sai Life Sciences Ltd
Average • 11w streak
+13.0%
← Back to Pharma - API & CRAMSDashboard

Frequently Asked Questions: Dishman Carbogen Amcis Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Dishman Carbogen Amcis Ltd's latest quarterly results?

Dishman Carbogen Amcis Ltd's latest quarterly results (Mar 2026) show

  • PAT Growth YoY: -48.8%
  • Revenue Growth YoY: +18.9%
  • Operating Margin: 19.0%

What is Dishman Carbogen Amcis Ltd's current PE ratio?

Dishman Carbogen Amcis Ltd's current PE ratio is 27.6x.

  • Current PE: 27.6x
  • Market Cap: 2.7K Cr

What is Dishman Carbogen Amcis Ltd's price-to-book ratio?

Dishman Carbogen Amcis Ltd's price-to-book ratio is 0.4x.

  • Price-to-Book (P/B): 0.4x
  • Book Value per Share: ₹426
  • Current Price: ₹174

Is Dishman Carbogen Amcis Ltd a fundamentally strong company?

Dishman Carbogen Amcis Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 3.0%

Is Dishman Carbogen Amcis Ltd debt free?

Dishman Carbogen Amcis Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹3,000 Cr

What is Dishman Carbogen Amcis Ltd's return on equity (ROE) and ROCE?

Dishman Carbogen Amcis Ltd's return ratios over recent years

  • FY2024: ROCE 0.0%
  • FY2025: ROCE 2.0%
  • FY2026: ROCE 3.0%

Is Dishman Carbogen Amcis Ltd's cash flow positive?

Dishman Carbogen Amcis Ltd's operating cash flow is positive (FY2026).

  • Cash from Operations (CFO): ₹491 Cr
  • Free Cash Flow (FCF): ₹246 Cr
  • CFO/PAT Ratio: 506% (strong cash conversion)

What is Dishman Carbogen Amcis Ltd's dividend yield?

Dishman Carbogen Amcis Ltd currently does not pay a significant dividend (yield 0.00%).

  • Dividend Yield: 0.00%
  • Current Price: ₹174

Who holds Dishman Carbogen Amcis Ltd shares — promoters, FII, DII?

Dishman Carbogen Amcis Ltd's shareholding pattern (Mar 2026)

  • Promoters: 59.3%
  • FII (Foreign): 7.5%
  • DII (Domestic): 1.6%
  • Public: 31.6%

Is promoter holding increasing or decreasing in Dishman Carbogen Amcis Ltd?

Dishman Carbogen Amcis Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 59.3% (Mar 2026)
  • Previous Quarter: 59.3% (Dec 2025)
  • Change: 0.00% (stable)

Is Dishman Carbogen Amcis Ltd a new momentum entry or an established outperformer?

Dishman Carbogen Amcis Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Dishman Carbogen Amcis Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Dishman Carbogen Amcis Ltd may be worth studying

  • Cash flow is positive — CFO ₹491 Cr

What is the investment thesis for Dishman Carbogen Amcis Ltd?

Dishman Carbogen Amcis Ltd investment thesis summary:

What is the future outlook for Dishman Carbogen Amcis Ltd?

Dishman Carbogen Amcis Ltd's forward outlook based on current data signals

  • Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.